(Q33793621)

29 July 2017

1 reference

title

Plasma and tissue kallikrein in arthritis and inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

29 July 2017

0 references

author name string

Colman RW

series ordinal

1

1 reference

29 July 2017

1 September 1999

1 reference

29 July 2017

1 reference

29 July 2017

43

1 reference

29 July 2017

103-108

1 reference

29 July 2017

2-3

1 reference

Involvement of endogenous kinins in the pathogenesis of peptidoglycan-induced arthritis in the Lewis rat

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900068-5

7 January 2021

Inhibition of plasma kallikrein prevents peptidoglycan-induced arthritis in the Lewis rat

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900068-5

7 January 2021

Stimulation of human neutrophil leukocyte aerobic glucose metabolism by purified chemotactic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900068-5

7 January 2021

Activation of Purified Human Plasma Prekallikrein Triggered by Cell Wall Fractions of Escherichia coli and Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900068-5

7 January 2021

A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900068-5

7 January 2021

Granulomatous enterocolitis induced in rats by purified bacterial cell wall fragments.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900068-5

7 January 2021

Selective kallikrein-kinin system activation in inbred rats differentially susceptible to granulomatous enterocolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900068-5

7 January 2021

Purified human plasma kallikrein aggregates human blood neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900068-5

7 January 2021

Selective plasma kallikrein inhibitor attenuates acute intestinal inflammation in Lewis rat

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900068-5

7 January 2021

Specific inhibition of plasma kallikrein modulates chronic granulomatous intestinal and systemic inflammation in genetically susceptible rats

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900068-5

7 January 2021

Kallikrein-kininogen system activation and bradykinin (B2) receptors in indomethacin induced enterocolitis in genetically susceptible Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900068-5

7 January 2021

Human plasma kallikrein releases neutrophil elastase during blood coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900068-5

7 January 2021

10.1016/S0162-3109(99)00068-5

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10596840